Evidence map›Paper›PMID 26985579›Full record

ArticleCNS oncology2016

Does valproic acid affect tumor growth and improve survival in glioblastomas?

Roberta Rudà, Alessia Pellerino, Riccardo Soffietti

Open access · bronzeAbstract readEditorial
In one paragraph

Article in CNS oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Histone Deacetylase Inhibitors as Anticancer Drugs.International journal of molecular sciences · 2017
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Roberta RudàDepartment of Neuro-Oncology, University & City of Health and Science Hospital, Via Cherasco 15, 10126, Turin, Italy.
Alessia PellerinoDepartment of Neuro-Oncology, University & City of Health and Science Hospital, Via Cherasco 15, 10126, Turin, Italy.
Riccardo SoffiettiDepartment of Neuro-Oncology, University & City of Health and Science Hospital, Via Cherasco 15, 10126, Turin, Italy.
Piedmont Reference Center for Epidemiology and Cancer Prevention · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnticonvulsantsAntineoplastic Agents, AlkylatingBrain NeoplasmsCell DifferentiationCell ProliferationCombined Modality TherapyDacarbazineGlioblastomaHistone Deacetylase InhibitorsHumansSeizuresTemozolomideValproic AcidAnticonvulsantsAntineoplastic Agents, AlkylatingDacarbazineHistone Deacetylase InhibitorsTemozolomideValproic Acidclinical studiesglioblastomasgliomaspreclinical studiesseizurestumor growthvalproic acid

Identifiers

PMID26985579
PMCPMC6047433
OpenAlexW2316200869

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.